Anzeige
Mehr »
Samstag, 14.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
48 Leser
Artikel bewerten:
(0)

Vendor Neutral Archive Market (VNA) Research Reports for Europe, N.A. and Asia

DALLAS, November 23, 2014 /PRNewswire/ --

ReportsnReports.com adds European Vendor Neutral Archive (VNA) Market, Asian Vendor Neutral Archive (VNA) Market and North American Vendor Neutral Archive (VNA) Market research reports to the life science intelligence collection of its online library.

The European Vendor Neutral Archive Market is expected to reach $93 million by 2018, at a CAGR of 15.69%. Europe is the second largest player in the global Vendor Neutral Archive Market, with a market share of 27% after North America. Complete report on vendor neutral archive market of Europe is available at http://www.reportsnreports.com/reports/313870-european-vendor-neutral-archive-vna-market.html .

The Asian Vendor Neutral Archive Market is expected to reach $19 million by 2018, at a CAGR of 13.38%. Asia holds around 7% market share of the global Vendor Neutral Archive Market. The Asian market is growing at a fast pace. Comprehensive table of contents and more on Asia's VNA market report is available at http://www.reportsnreports.com/reports/313871-asian-vendor-neutral-archive-vna-market.html .

The North American vendor neutral archive market is expected to reach $204 million by 2018, at a CAGR of 13.89% during the forecast period, 2013 to 2018. North America is the leader in the global vendor neutral archive market, due to the advancements in technology, higher awareness rate amongst patients, and so on. North America accounts for nearly 64% of the global market. In North America, the U.S. leads the market with a share of 92%. Read more on this research at http://www.reportsnreports.com/reports/313869-north-american-vendor-neutral-archive-vna-market.html .

These reports analyze the market on the basis of its delivery mode, deployment model, and supplier type. In the delivery mode segment, on-premise VNA forms the largest segment of the overall VNA market, as on-premise VNAs are perceived to offer better control and secure sharing of data. However, the hybrid VNA is expected to be the fastest-growing segment, and consequently, a new revenue-generating segment for the players in this market. Hybrid VNAs allow the cloud to store all the second copies of images, thereby significantly reducing the cost of disaster recovery. By groups, the market analysis covers PACS vendors, independent software vendors (ISVs) and infrastructure vendors. By types, the industry information is for departmental model, multi-departmental model and multi-side model of each regions.

The growth of the VNA market, globally, is propelled by factors such as favorable government regulations for top markets, and the growing demand for standard-based storage, disaster recovery, and lifecycle management solutions. The major factors restricting the growth of this market are data breach incidences, misinterpretation of the VNA concept, and long VNA lifecycles that impact the buying decisions of users.

The report also provides an extensive competitive landscaping of the leading companies operating in this market. Acuo Technologies (U.S.) is the market leader, followed by other major players such as Agfa HealthCare (Belgium), Carestream Health (U.S.), BridgeHead Software (U.K.), Dell, Inc. (U.S.), GE Healthcare (U.K.), Fujifilm Corporation (Japan), Merge Health (U.S.), Philips Healthcare (The Netherlands), Siemens Healthcare (Germany), McKesson Corporation (U.S.), and TeraMedica (U.S.). Furthermore, the segment and country-specific company shares, news & deals, M&A, segment-specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report.

The Vendor Neutral Archive Market & PACS Market - VNA [On-premise Software, Hybrid & Cloud, Multi-Department & Multi-Site VNA] & Picture Archiving and Communication System [Enterprise, Cardiology & Radiology] - Global Forecast to 2018 research report (http://www.reportsnreports.com/reports/269003-vendor-neutral-archive-market-pacs-market-vna-on-premise-software-hybrid-cloud-multi-department-multi-site-vna-picture-archiving-and-communication-system-enterprise-cardiology-radiology-global-forecast-to-2018.html ) says that global VNA market was estimated to be valued at $165.3 million in 2013 and is expected to reach $335.4 million by 2018, at a healthy CAGR of 15.2%. The Picture Archiving and Communication System market is broadly categorized into departmental PACS and enterprise PACS. Departmental PACS dominates the revenue market with a market share of around 90.8% in 2013. The departmental PACS market is segmented into radiology, cardiology, and other departmental PACS. Radiology PACS accounts for the largest share-63%-of the departmental PACS market owing to the increasing volumes of diagnostic images in this department. Companies profiled in this research include ACUO Technologies (Perceptive Software), AGFA Healthcare, Bridgehead Software, Carestream Health, Inc., Dejarnette Research Systems, Inc., Dell, Inc., Fujifilm Corporation, GE Healthcare, Mach 7 Technologies, Mckesson Corporation, Merge Healthcare, Novarad Corporation, Philips Healthcare, Siemens Healthcare and Teramedica. Order a copy of this report at http://www.reportsnreports.com/Purchase.aspx?name=269003 .

Explore more reports on medical devices market as well as other research by Micro Market Monitor at http://www.reportsnreports.com/publisher/micromarketmonitor/ .

About Us:

ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.

Contact:
Priyank Tiwari
TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252
Tel: +1-888-391-5441
sales@reportsandreports.com

Connect With Us on:

Facebook: http://www.facebook.com/pages/ReportsnReports/191441427571689

LinkedIn: http://www.linkedin.com/company/reportsnreports

Twitter: https://twitter.com/marketsreports

G+ / Google Plus:https://plus.google.com/111656568937629536321/posts

Pinterest: http://www.pinterest.com/comeonseo/reportsnreports/

RSS/Feeds: http://www.reportsnreports.com/feed/l-latestreports.xml


© 2014 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.